RECRUITING Not applicable ClinicalTrials.gov

Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression

Sponsor: University of Manitoba • ClinicalTrials.gov ID: NCT06651801

Registry updated: 2026-10-14

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Description

The goal of this clinical trial is to evaluate the feasibility and acceptability of the intervention, Group Medical Visits (GMVs), for patients with depression and anxiety. It also aims to get some initial information on the effectiveness of GMVs on reducing depression and anxiety scores, which will help inform power calculations for a future larger randomized controlled trial (RCT). The main question it aims to answer is: * Are GMVs feasible and acceptable to patients with depression and anxiety? This study consists of a pilot RCT with an intervention and control arm. At enrollment, participants will be randomized to the intervention group, 6 months of GMVs, or to the control group, which consists of "standard client services". For the GMV group, participants will engage in a biweekly virtual group that is similar to a standard psychiatric follow-up. Participants in the control group will receive standard care after a psychiatric assessment, which includes follow-up with their primary care provider (family physician or nurse practitioner), individual psychiatric care if suggested by the psychiatrist who did their psychiatric assessment, and/or a referral to publicly funded therapy groups if interested.

Interventions

Group Medical Visits (Behavioral)
Group medical visits occur every 2 weeks virtually (via Zoom) for 6 months. Each group consists of 45 minutes of group time and 5 minute individual check-in appointments. The group time consists of psychoeducation, group support, and medication follow-up.

Eligibility criteria

Inclusion Criteria: * Adult patients who are looking for longitudinal psychiatric follow-up after a one-time consult or discharge from a mental health program. * Primary mental health issue is an anxiety or depressive disorder. * Able to commit to a virtual biweekly group on Tuesdays from 2:30-4PM. * Able to do virtual group from a private location with camera access. * Live in community in Manitoba and plan to stay for a 6-month period. Exclusion Criteria: * Patients with confirmed Bipolar 1 or 2 Disorder. * Patients who already have longitudinal care with a psychiatrist. * Received ECT treatment within past 6 months. * Concern about safety of other group members/facilitators if this patient were to join. * Any co-morbidity/behaviour that would significantly impact ability to participate in the group. For example: * Severe substance use disorder. * Significant PTSD or OCD symptoms that would impact group participation. * Severe personality disorder. * Current psychotic symptoms. * Moderate to severe intellectual disability or neurocognitive disorder. * Current significant eating disorder symptoms. * Self-harm behaviour requiring medical/psychiatric attention or suicide attempt within the past 6 months.

Conditions

Mental Health Care Anxiety and Depression Pilot Study

Locations

PsycHealth Centre — Winnipeg, Manitoba, Canada

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record

Accelerate Your Clinical Trial Recruitment